In vitiligo lesions, CD122 and CD132 are expressed on MSA-specific CD8+ TRM, whereas CD215 is expressed on keratinocytes with an ability to present IL-15 to T cells in trans (48). The gene discussed is IL2RB; the disease is vitiligo.